MicroPort Orthopedics Gets Market Access Boon from VBP Company Revenue The Numbers The company's 1H22 revenue declined in the low single digits due to currency pressures but it expanded market access by hundreds of hospitals. Sep 06, 2022
LimaCorporate Rides Strong Rebounds in Europe and U.S. Company Revenue The Numbers The company grew in the mid-teens for 2Q22, driven by strong COVID recoveries in most European countries along with the U.S. Sep 01, 2022
Narrowly Focused Companies Generating Significant Growth Chart of the Month The Numbers Our chart of the month for September examines five focused companies growing at many multiples of their respective markets. Aug 29, 2022
Medtronic Gains Offset by China VBP and Biologics Company Revenue The Numbers Despite share gains in its U.S. core spine products, Medtronic declined in the mid-single digits due to VBP in China and biologics declines. Aug 24, 2022
Orthopedic Companies Report Choppy Second Quarter of 2022 Market Analysis The Numbers We estimate orthopedic sales were essentially flat against the prior year as the market faced difficult comparisons and macro headwinds. Aug 24, 2022
Medartis Revises 2022 Outlook Based on Headwinds Company Revenue The Numbers The company grew in the high teens for 1H22 but lowered its full-year guidance due to OR staffing headwinds and slower U.S. growth. Aug 18, 2022
Amplitude Surgical Growth Bolstered by Novastep Line Company Revenue The Numbers The company grew in the high single digits for its fiscal year 2022, driven in part by gains in its Novastep foot and ankle business. Aug 18, 2022
Medacta Continues Ascent in First Half of 2022 Company Revenue The Numbers The company grew in the high teens for 1H22, driven by an expanded salesforce and further adoption of the NextAR surgical platform. Aug 17, 2022
Treace Medical Continues Gains Across Key Metrics Company Revenue The Numbers The company grew +45% in 2Q22 by driving increased market penetration and product utilization among its surgeon population. Aug 15, 2022
SI-BONE Sees Robust Demand and Increasing Utilization Company Revenue The Numbers The company grew in the mid-teens for the second quarter of 2022, attaining the most active surgeons in company history. Aug 15, 2022